The Potential Impact of SGLT2-I in Diabetic Foot Prevention: Promising Pathophysiologic Implications, State of the Art, and Future Perspectives-A Narrative Review.
SGLT2-I 在糖尿病足預防中的潛在影響:有前景的病理生理意涵、最新進展及未來展望 - 敘述性綜述。
Medicina (Kaunas) 2024-11-27
Role of NLRP3 Inflammasome in Heart Failure Patients Undergoing Cardiac Surgery as a Potential Determinant of Postoperative Atrial Fibrillation and Remodeling: Is SGLT2 Cotransporter Inhibition an Alternative for Cardioprotection?
NLRP3 炎症小體在接受心臟手術的心衰竭患者中的角色:作為術後心房顫動和重塑的潛在決定因素,SGLT2 協同轉運蛋白抑制是否為心臟保護的替代方案?
Antioxidants (Basel) 2024-11-27
Impact of exercise training in combination with dapagliflozin on physical function in adults with type 2 diabetes mellitus: study protocol for the Dapagliflozin, Exercise Training and physicAl function (DETA) randomised controlled trial.
運動訓練結合 dapagliflozin 對 2 型糖尿病成人身體功能的影響:Dapagliflozin、Exercise Training 和身體功能 (DETA) 隨機對照試驗的研究計劃。
BMJ Open 2024-11-26
Effects of canagliflozin on brain natriuretic peptide levels in patients with type 2 diabetes on peritoneal dialysis in Japan: protocol for a multicentre, prospective, randomised controlled trial (CARD-PD trial).
在日本接受腹膜透析的2型糖尿病患者中,canagliflozin對腦鈉尿肽水平的影響:多中心、前瞻性、隨機對照試驗(CARD-PD trial)方案。
BMJ Open 2024-11-26
Impact of <i>Opuntia ficus-indica</i> Juice and Empagliflozin on Glycemic Control in Rats.
<i>Opuntia ficus-indica</i> 果汁和 Empagliflozin 對大鼠血糖控制的影響。
Curr Issues Mol Biol 2024-11-26
Coronary Plaque Regression and Fractional Flow Reserve Improvement in a Chronic Coronary Syndrome Case: Early Optimal Medical Therapy and Fractional Flow Reserve-Computed Tomography Follow-Up Strategy.
慢性冠狀動脈症候群案例中的冠狀動脈斑塊回歸與分數性血流儲備改善:早期最佳藥物治療與分數性血流儲備-電腦斷層後續策略。
Diseases 2024-11-26
The potential role of Sodium/Glucose Cotransporter 2 inhibitors in the treatment of cystinuria.
鈉/葡萄糖共轉運蛋白 2 抑制劑在胱氨酸尿症治療中的潛在角色。
Urolithiasis 2024-11-26